{
    "eid": "2-s2.0-85068729869",
    "title": "LKB1 and KEAP1/NRF2 pathways cooperatively promote metabolic reprogramming with enhanced glutamine dependence inKRAS-mutant lung adenocarcinoma",
    "cover-date": "2019-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [],
    "authors": [
        "Ana Galan-Cobo",
        "Piyada Sitthideatphaiboon",
        "Xiao Qu",
        "Alissa Poteete",
        "Marlese A. Pisegna",
        "Pan Tong",
        "Pei Hsuan Chen",
        "Lindsey K. Boroughs",
        "Mirna L.M. Rodriguez",
        "Winter Zhang",
        "Francesco Parlati",
        "Jing Wang",
        "Varsha Gandhi",
        "Ferdinandos Skoulidis",
        "Ralph J. DeBerardinis",
        "John D. Minna",
        "John V. Heymach"
    ],
    "citedby-count": 167,
    "ref-count": 55,
    "ref-list": [
        "Effect of KRAS oncogene substitutions on protein behavior: Implications for signaling and clinical outcome",
        "Somatic mutations affect key pathways in lung adenocarcinoma",
        "Characterizing the cancer genome in lung adenocarcinoma",
        "Co-occurring genomic alterations define major subsets of KRASmutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities",
        "K-ras activation generates an inflammatory response in lung tumors",
        "The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress",
        "AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress",
        "A central role for mTOR in lipid homeostasis",
        "LKB1 inactivation elicits a redox imbalance to modulate non-small cell lung cancer plasticity and therapeutic response",
        "The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer",
        "Targeting glutamine metabolism sensitizes pancreatic cancer to PARPdriven metabolic catastrophe induced by \u00df-lapachone",
        "Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer",
        "Blockage of glutaminolysis enhances the sensitivity of ovarian cancer cells to PI3K/mTOR inhibition involvement of STAT3 signaling",
        "Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition",
        "Glutaminase regulation in cancer cells: A druggable chain of events",
        "Targeted inhibition of EGFR and glutaminase induces metabolic crisis in EGFR mutant lung cancer",
        "Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells",
        "Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis",
        "Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras",
        "Sulforhodamine B colorimetric assay for cytotoxicity screening",
        "A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue",
        "Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming",
        "LKB1 deficiency enhances sensitivity to energetic stress induced by erlotinib treatment in non-small-cell lung cancer (NSCLC) cells",
        "LKB1 reduces ROSmediated cell damage via activation of p38",
        "High levels of Nrf2 determine chemoresistance in type II endometrial cancer",
        "Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin",
        "Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer",
        "Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy",
        "Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer",
        "Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features",
        "Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2",
        "Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth",
        "Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer",
        "Chemical proteomics identifies druggable vulnerabilities in a genetically defined cancer",
        "Transcriptional regulation by Nrf2",
        "The Nrf2 regulatory network provides an interface between redox and intermediary metabolism",
        "The GSK3 signaling axis regulates adaptive glutamine metabolism in lung squamous cell carcinoma",
        "Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis",
        "Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis",
        "Glutamine addiction: A new therapeutic target in cancer",
        "Capturing the metabolomic diversity of KRAS mutants in non-small-cell lung cancer cells",
        "Comparative metabolomics profiling of isogenic KRAS wild type and mutant NSCLC cells in vitro and in vivo",
        "Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway",
        "Oncogenic KRas decouples glucose and glutamine metabolismto support cancer cell growth",
        "Targeting metabolic reprogramming in KRASdriven cancers",
        "Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1a",
        "LKB1 promotes metabolic flexibility in response to energy stress",
        "The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition",
        "Heightening energetic stress selectively targets LKB1-deficient non-small cell lung cancers",
        "Glucose availability is a decisive factor for Nrf2-mediated gene expression",
        "Glucose metabolism and NRF2 coordinate the antioxidant response in melanoma resistant to MAPK inhibitors",
        "Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer",
        "Pyruvate carboxylase is required for glutamine-independent growth of tumor cells",
        "Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport",
        "Pan-cancer metabolic signature predicts codependency on glutaminase and de novo glutathione synthesis linked to a high-mesenchymal cell state"
    ],
    "affiliation": [
        {
            "affiliation-city": "Houston",
            "@id": "60015023",
            "affilname": "The University of Texas MD Anderson Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015023",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Dallas",
            "@id": "60092486",
            "affilname": "Harold C. Simmons Comprehensive Cancer Center, Dallas",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60092486",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Jinan",
            "@id": "60031031",
            "affilname": "Shandong University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031031",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Houston",
            "@id": "60027512",
            "affilname": "University of Texas Health Science Center at Houston",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027512",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Dallas",
            "@id": "60014739",
            "affilname": "UT Southwestern Medical School",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014739",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Boston",
            "@id": "60014334",
            "affilname": "Dana-Farber Cancer Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014334",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "San Francisco",
            "@id": "109644026",
            "affilname": "Calithera Biosciences",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/109644026",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "Jane Ford Petrin donation",
        "University of Texas South-western Medical Center",
        "American Association for Cancer Research",
        "CPRIT",
        "University of Texas MD Anderson Cancer Center Lung UT",
        "University of Texas Southwestern Medical Center",
        "Stand Up To Cancer-American Cancer Society"
    ]
}